KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $177.6 million.

  • Charles River Laboratories International's Operating Expenses fell 1085.47% to $177.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.6 million, marking a year-over-year decrease of 130.14%. This contributed to the annual value of $751.0 million for FY2024, which is 42.09% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Operating Expenses stood at $177.6 million, which was down 1085.47% from $191.5 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Operating Expenses peaked at $199.8 million during Q3 2023, and registered a low of $131.7 million during Q2 2022.
  • Over the past 5 years, Charles River Laboratories International's median Operating Expenses value was $177.6 million (recorded in 2025), while the average stood at $175.3 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first crashed by 2320.1% in 2022, then skyrocketed by 5166.39% in 2023.
  • Over the past 5 years, Charles River Laboratories International's Operating Expenses (Quarter) stood at $144.1 million in 2021, then surged by 38.53% to $199.6 million in 2022, then fell by 1.25% to $197.1 million in 2023, then dropped by 0.73% to $195.7 million in 2024, then dropped by 9.26% to $177.6 million in 2025.
  • Its last three reported values are $177.6 million in Q3 2025, $191.5 million for Q2 2025, and $177.8 million during Q1 2025.